Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruby C Y Lin

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|September 12, 2022
3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studiesHuaikai Shi, Emma M Rath, Ruby C Y Lin, et al.
Plos One|March 4, 2014
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathyBianca C Bernardo, Xiao-Ming Gao, Yow Keat Tham, et al.
Molecular Cancer|June 2, 2016
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaYuen Yee Cheng, Casey M Wright, Michaela B Kirschner, et al.
Brain : a Journal of Neurology|November 16, 2022
Novel gene-intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathyAnthony N Cutrupi, Ramesh K Narayanan, Gonzalo Perez-Siles, et al.
Diabetes|March 14, 2014
Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophyLu Liu, Qingqing Jiang, Xuhong Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2017
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural MesotheliomaThomas G Johnson, Karin Schelch, Yuen Y Cheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2014
Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophyBianca C Bernardo, Sally S Nguyen, Catherine E Winbanks, et al.
The American Journal of Pathology|August 15, 2009
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillationLynette Pretorius, Xiao-Jun Du, Elizabeth A Woodcock, et al.
Oncotarget|July 1, 2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaMarissa Williams, Michaela B Kirschner, Yuen Yee Cheng, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2010
PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNARuby C Y Lin, Kate L Weeks, Xiao-Ming Gao, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|September 12, 2022
3-Dimensional mesothelioma spheroids provide closer to natural pathophysiological tumor microenvironment for drug response studiesHuaikai Shi, Emma M Rath, Ruby C Y Lin, et al.
Plos One|March 4, 2014
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathyBianca C Bernardo, Xiao-Ming Gao, Yow Keat Tham, et al.
Molecular Cancer|June 2, 2016
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaYuen Yee Cheng, Casey M Wright, Michaela B Kirschner, et al.
Brain : a Journal of Neurology|November 16, 2022
Novel gene-intergenic fusion involving ubiquitin E3 ligase UBE3C causes distal hereditary motor neuropathyAnthony N Cutrupi, Ramesh K Narayanan, Gonzalo Perez-Siles, et al.
Diabetes|March 14, 2014
Adipose-specific knockout of SEIPIN/BSCL2 results in progressive lipodystrophyLu Liu, Qingqing Jiang, Xuhong Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2017
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural MesotheliomaThomas G Johnson, Karin Schelch, Yuen Y Cheng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 23, 2014
Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophyBianca C Bernardo, Sally S Nguyen, Catherine E Winbanks, et al.
The American Journal of Pathology|August 15, 2009
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillationLynette Pretorius, Xiao-Jun Du, Elizabeth A Woodcock, et al.
Oncotarget|July 1, 2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaMarissa Williams, Michaela B Kirschner, Yuen Yee Cheng, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 19, 2010
PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNARuby C Y Lin, Kate L Weeks, Xiao-Ming Gao, et al.
Pageof 6